Search Results
Feb 18, 2026, 18:01 ET Dyson Launches PencilWash™ the Slimmest (1), Ultra-Light, and Hygienic Wet and Dry Cleaner
1.5in diameter10.5in (L) x 7.8in (W) x 45.6in (H)Lays flat
More news about: Dyson
Feb 18, 2026, 17:31 ET Phenylketonuria Market to Reach New Heights by 2034, Driven by Innovative Therapies and Rising Diagnosis Rates | DelveInsight
study. In early clinical evaluations, five of six patients receiving the high dose maintained plasma phenylalanine (Phe) concentrations near 120 µmol/L for up to 32 weeks after a single administration. Long-term safety and efficacy outcomes are being assessed in the ongoing trial.Jnana Therapeutics'
More news about: DelveInsight Business Research, LLP
Feb 18, 2026, 17:00 ET OceanaGold Reports Mineral Reserves and Resources for the Year Ended 2025
underground, Gladstone open pit and Martha Open Pit has been verified and approved by, or is based on information prepared by, or under the supervision of, L. Crawford-Flett, the Company's Manager – Exploration and Geology, Waihi. The Mineral Reserves estimate for Martha underground has been verified and approved
More news about: OceanaGold Corporation
Feb 18, 2026, 16:05 ET BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
Bausch Health (excl. B+L) (non-GAAP) to be meaningful information and utilizes it in decision making and for compensation purposes. Adjusted EBITDA for Bausch Health Excluding B+L (non-GAAP) is not intended to be representative of GAAP continuing operations and Adjusted EBITDA for B+L is not intended to
More news about: Bausch Health Companies Inc.
Feb 18, 2026, 15:22 ET Greenberg Traurig's Erica Okerberg Named to 'Next Generation of Leaders' by Corporate Counsel 2026 Women, Influence & Power in Law Awards
Erica L. Okerberg was selected for the "Next Generation of Leaders" award by the Corporate Counsel 2026 Women, Influence & Power in Law (WIPL)
More news about: Greenberg Traurig, LLP
Feb 18, 2026, 15:00 ET Life Time Ignites the Pilates and Reformer Boom as Demand Surges Coast to Coast
healthy, happy lives through its 190 athletic country clubs across the U.S. and Canada, the complimentary and comprehensive Life Time app featuring its L•AI•C™ AI-powered health companion, and more than 30 iconic athletic events. Serving people ages 90 days to 90+ years, the Life Time ecosystem uniquely delivers
More news about: Life Time, Inc.
Feb 18, 2026, 14:30 ET Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA
Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. Erratum in: N Engl J Med. 2017 Oct 26;377(17):1700. doi: 10.1056/NEJMx170015.4. Winstedt L, et al. Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic
More news about: Hansa Biopharma AB
Feb 18, 2026, 14:28 ET Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA
Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. Erratum in: N Engl J Med. 2017 Oct 26;377(17):1700. doi: 10.1056/NEJMx170015.4. Winstedt L, et al. Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic
More news about: Hansa Biopharma AB
Feb 18, 2026, 13:32 ET Kyowa Hakko Clarifies Glutathione Misconceptions with Science-Backed Insights on Quality and Efficacy of its Industry-Leading Setria® Brand
it supports skin health, with a 12-week study demonstrating reductions in melanin. In sports nutrition, studies indicate that when combined with L-citrulline, Setria helps increase nitric oxide to support performance, as reviewed in the Journal of Exercise and Nutrition.These benefits align with
More news about: Kyowa Hakko U.S.A
Feb 18, 2026, 13:32 ET O'Toole Secures Conditional Pardon in Second Clemency Victory
2026 /PRNewswire/ -- Brendan D. O'Toole, a litigation partner at Williams Mullen, has secured a Conditional Pardon for his pro bono client, Jerry L. James, resulting in his release from prison after more than two decades of incarceration.
More news about: Williams Mullen
Feb 18, 2026, 13:07 ET Bitmine Immersion Technologies (BMNR) Umumkan Kepemilikan ETH Mencapai 4,371 Juta Token dan Total Kepemilikan Kripto Maupun Total Uang Tunai Sebesar $9,6 Miliar
Ethereum untuk mengumpulkan pembayaran dan verifikasi, dan (iii) kreator cenderung menggunakan 'proof of human' dan standar lain yang dijalankan di Ethereum L2 (Worldchain, dan lain-lain). Banyak diskusi panel dan presentasi mengenai 3 topik ini. Dan jelas bahwa Ethereum siap mendapatkan pangsa pasar yang signifikan
More news about: Bitmine Immersion Technologies, Inc.
Feb 18, 2026, 11:58 ET Travelpro Products Appoints Lori H. Gonzalez as Chief Executive Officer
designer and manufacturer of home furnishings and electric fireplaces. During her tenure, she led a comprehensive turnaround, transforming the company's P&L and operating model within the first 18 months. Under her leadership, she shifted the business from a highly seasonal model to a diversified, omnichannel
More news about: Travelpro
Feb 18, 2026, 10:00 ET Grant & Eisenhofer P.A. and Levi & Korsinsky, LLP Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Class Action for All Record and Beneficial Holders of Experience Investment Corp. Class A Common Stock Who Purchased, Acquired, or Held Such Securities at Any Time Between September 17, 2019 and May 3, 2021
Plaintiffs,v.ERIC L. AFFELDT, MARTIN NEWBURGER, BRIAN C. WITHEROW, RAFAEL PASTOR, TED PHILLIP, CHARLIE MARTIN, MICHAEL MOHAPP, and EXPERIENCE
More news about: Grant & Eisenhofer P.A. and Levi & Korsinsky, LLP
Feb 18, 2026, 09:32 ET True Citrus Launches Innovative True Lemon Wellness Line for Cravings, Immunity and Energy Support
Proprietary Phyto True™ Energy & Focus Blend (120 mg of plant-based caffeine from green tea extract to help avoid crash or jitters, 200mg of L-Theanine, 200mg of GABA and 60mg magnesium to help support sustained focus, mental clarity and overall mood); Vitamin C (100% DV) to energize
More news about: True Citrus
Feb 18, 2026, 09:03 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
sterilization, freeze-thawing and homogenization. Front Nutr. Published online September 15, 2022. doi:10.3389/fnut.2022.926814 Meredith-Dennis L, Xu G, Goonatilleke E, Lebrilla CB, Underwood MA, Smilowitz JT. Composition and variation of macronutrients, immune proteins, and human milk oligosaccharides
More news about: Prolacta Bioscience
Feb 18, 2026, 09:00 ET DailyPay Announces Appointment of Jennifer R. Jackson to its Board of Directors
Walmart, she served as SVP of Enterprise Strategy and Innovation.Prior to Walmart, Jackson spent nearly a decade at Capital One, holding executive P&L roles. As President of Capital One Canada, she led the multi-billion dollar credit card business through crises and digital transformation. In the
More news about: DailyPay
Feb 18, 2026, 09:00 ET Covr Appoints Ryan Bivins as Head of Sales to Accelerate Growth and Deepen Carrier Partnerships
contractual agreements with its insurance carrier providers. Covr is licensed in the following states: Delaware (3000067942), Idaho (607086), California (0L77229). All other state license numbers are available on our State License Disclosure Page.
More news about: Covr Financial Technologies
Feb 18, 2026, 09:00 ET Keurig Dr Pepper Announces Flavorful New Innovation Across Its Refreshment Portfolio
ending 12.29.20244 Source: Mintel, Spring/Summer Flavors on the Menu 20245 Source: Circana, MULO+ w/ Convenience L52W ending 12.28.25
More news about: Keurig Dr Pepper
Feb 18, 2026, 08:56 ET GunsAmerica Names Best of SHOT Show 2026 Editor's Choice Award Winners
SPXBest Pistol: Kimber DS WarriorBest Accessory: Magne-Tech Magnetic Scope MountBest Optic: Garmin Zero L60i Laser RangefinderBest Suppressor: Ambient Arms SuppressorsEditor's Choice: Nocpix Quest H50R Thermal BinocularBest
More news about: GunsAmerica
Feb 18, 2026, 08:50 ET Draper Achieves Sustained Recirculation of Immune Cells in a Microphysiological System (MPS)
Haroutunian, Ryan Dubay, Joseph N. Urban, Anthony Quinnert, Brett C. Isenberg, Samuel H. Kann, Halee Kim, Robert Gaibler, Hesham Azizgolshani, Elizabeth L. Wiellette, and Corin Williams.
More news about: Draper Laboratory
Feb 18, 2026, 08:04 ET Bitmine Immersion Technologies (BMNR) annonce que les avoirs en ETH atteignent 4,371 millions de tokens, et que le total des avoirs en crypto-monnaie et en liquidités s'élève à 9,6 milliards de dollars
des paiements que pour la vérification et (iii) les créateurs s'orientant vers la « preuve d'humanité » et d'autres normes fonctionnant sur Ethereum L2 (Worldchain, etc.). De nombreuses discussions et présentations ont permis d'aborder ces trois sujets, et il est évident qu'Ethereum est bien placé pour
More news about: Bitmine Immersion Technologies, Inc.
Feb 18, 2026, 07:50 ET Bitmine Immersion Technologies (BMNR) maakt bekend dat het 4,371 miljoen ETH-tokens in bezit heeft en dat het totale bezit aan cryptovaluta en contanten USD 9,6 miljard bedraagt.
voor zowel het verzamelen van betalingen als voor verificatie en (iii) makers die geneigd zijn naar 'proof of human' en andere normen die op Ethereum L2 (Worldchain, etc.) draaien. Er waren vele paneldiscussies en presentaties rond deze drie onderwerpen. Het is duidelijk dat Ethereum goed gepositioneerd
More news about: Bitmine Immersion Technologies, Inc.
Feb 18, 2026, 07:45 ET Singular Genomics Launches G4X™ in the U.S., Delivering Industry-Leading Throughput for In Situ Multiomics, Targets Translational and Clinical Applications
datasets." "The G4X platform allowed us to analyze a large section of tissue from many samples without sacrificing on resolution and sensitivity," said Roderick L. Beijersbergen, PhD, Group Leader and Head of the NKI Robotics and Screening Center, Netherlands Cancer Institute. "The ability to address multiple
More news about: Singular Genomics
Feb 18, 2026, 07:35 ET Knight Therapeutics anuncia a submissão regulatória de NIKTIMVO® (axatilimabe) no Brasil
of the American Society for Blood and Marrow Transplantation, vol. 13, nº 10 (2007): 1207-1215. doi:10.1016/j.bbmt.2007.07.001Kitko, Carrie L et al. "Axatilimabe para doença crônica do enxerto contra o hospedeiro após falha de pelo menos duas terapias sistêmicas anteriores: resultados de um
More news about: Knight Therapeutics Inc.
Feb 18, 2026, 07:35 ET Knight Therapeutics anuncia la solicitud de autorización regulatoria de NIKTIMVO® (axatilimab) en Brasil
of the American Society for Blood and Marrow Transplantation, vol. 13, núm. 10 (2007): 1207-1215. doi:10.1016/j.bbmt.2007.07.001Kitko, Carrie L et al. "Axatilimab para la enfermedad crónica injerto contra huésped después del fracaso de al menos dos terapias sistémicas previas: resultados de un
More news about: Knight Therapeutics Inc.